US Stock MarketDetailed Quotes

FULC Fulcrum Therapeutics

Watchlist
  • 3.250
  • +0.280+9.43%
Close Nov 22 16:00 ET
  • 3.250
  • 0.0000.00%
Post 16:02 ET
175.30MMarket Cap-11206P/E (TTM)

Fulcrum Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
16.74%-19.07M
383.37%58.9M
-4.84%-25.28M
6.27%-90.97M
-17.58%-23.16M
17.85%-22.91M
24.05%-20.79M
-9.09%-24.12M
-23.67%-97.05M
9.89%-19.7M
Net income from continuing operations
9.66%-21.7M
332.98%55.41M
-8.44%-26.87M
11.41%-97.34M
5.28%-24.76M
-1.18%-24.02M
30.19%-23.78M
4.43%-24.78M
-35.90%-109.87M
-11.29%-26.14M
Depreciation and amortization
-30.51%369K
-33.69%376K
-15.37%479K
-10.02%2.17M
-14.04%508K
-13.09%531K
-16.12%567K
5.60%566K
-4.02%2.41M
-4.83%591K
Change In working capital
73.92%-410K
-112.31%-96K
40.93%-1.65M
-49.10%-4.61M
-132.43%-1.03M
80.88%-1.57M
-72.74%780K
-205.25%-2.79M
73.98%-3.09M
200.16%3.18M
-Change in receivables
-1,840.79%-1.32M
-318.85%-2.33M
313.08%537K
-109.04%-308K
-92.51%43K
-74.41%76K
-86.91%-557K
-95.41%130K
408.14%3.41M
123.25%574K
-Change in prepaid assets
-250.29%-2.42M
-39.40%463K
253.83%803K
-530.59%-1.07M
-181.20%-622K
27.99%-692K
1,176.06%764K
-643.75%-522K
-26.87%-170K
75.69%766K
-Change in payables and accrued expense
369.48%1.6M
107.17%1.94M
-33.63%-2.82M
-170.21%-1.68M
-96.27%92K
91.53%-593K
-83.92%934K
-11.81%-2.11M
-121.25%-621K
546.98%2.47M
-Change in other current assets
38,160.00%1.91M
-102.78%-1K
-68.92%23K
106.02%94K
-250.00%-21K
-28.57%5K
102.79%36K
127.01%74K
-4,438.89%-1.56M
73.91%-6K
-Change in other working capital
52.72%-174K
59.70%-160K
47.37%-190K
60.26%-1.65M
15.65%-523K
34.05%-368K
69.18%-397K
78.55%-361K
69.51%-4.15M
58.64%-620K
Cash from discontinued investing activities
Operating cash flow
16.74%-19.07M
383.37%58.9M
-4.84%-25.28M
6.27%-90.97M
-17.58%-23.16M
17.85%-22.91M
24.05%-20.79M
-9.09%-24.12M
-23.67%-97.05M
9.89%-19.7M
Investing cash flow
Cash flow from continuing investing activities
-77.13%4.35M
-162.93%-12.51M
140.59%38.13M
-395.59%-36.69M
150.48%18.35M
934.58%19.02M
-36.69%19.88M
-577.85%-93.94M
109.57%12.41M
-299.85%-36.36M
Net PPE purchase and sale
70.77%-19K
--0
83.63%-28K
74.12%-508K
33.62%-77K
77.03%-65K
85.20%-195K
30.49%-171K
-14.59%-1.96M
77.65%-116K
Net investment purchase and sale
-77.11%4.37M
-162.32%-12.51M
140.69%38.16M
-351.70%-36.18M
150.85%18.43M
1,056.16%19.09M
-38.65%20.07M
-571.09%-93.77M
111.24%14.38M
-322.69%-36.25M
Cash from discontinued investing activities
Investing cash flow
-77.13%4.35M
-162.93%-12.51M
140.59%38.13M
-395.59%-36.69M
150.48%18.35M
934.58%19.02M
-36.69%19.88M
-577.85%-93.94M
109.57%12.41M
-299.85%-36.36M
Financing cash flow
Cash flow from continuing financing activities
635K
165.49%377K
-98.60%1.65M
40.08%118.12M
31.65%287K
0
-94.95%142K
33,719.83%117.69M
-54.79%84.32M
-75.53%218K
Net common stock issuance
--0
--0
--0
45.22%117.35M
--0
--0
--0
--117.35M
-55.81%80.8M
36.36%-49K
Proceeds from stock option exercised by employees
--635K
165.49%377K
374.43%1.65M
-77.92%777K
7.49%287K
--0
-94.95%142K
0.00%348K
-4.06%3.52M
-72.45%267K
Cash from discontinued financing activities
Financing cash flow
--635K
165.49%377K
-98.60%1.65M
40.08%118.12M
31.65%287K
--0
-94.95%142K
33,719.83%117.69M
-54.79%84.32M
-75.53%218K
Net cash flow
Beginning cash position
150.78%87.92M
14.86%41.15M
-26.35%26.66M
-0.86%36.19M
-66.13%31.17M
-15.00%35.06M
4.13%35.83M
-0.86%36.19M
-37.22%36.5M
38.26%92.03M
Current changes in cash
-262.51%-14.09M
6,189.58%46.77M
4,082.14%14.5M
-2,936.62%-9.54M
91.91%-4.52M
-107.65%-3.89M
-111.23%-768K
82.66%-364K
98.55%-314K
-85.76%-55.84M
End cash Position
136.85%73.83M
150.78%87.92M
14.86%41.15M
-26.35%26.66M
-26.35%26.66M
-66.13%31.17M
-15.00%35.06M
4.13%35.83M
-0.86%36.19M
-0.86%36.19M
Free cash flow
16.89%-19.09M
380.74%58.9M
-4.22%-25.31M
7.62%-91.47M
-17.28%-23.24M
18.44%-22.97M
26.86%-20.98M
-8.66%-24.29M
-23.47%-99.01M
11.46%-19.81M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 16.74%-19.07M383.37%58.9M-4.84%-25.28M6.27%-90.97M-17.58%-23.16M17.85%-22.91M24.05%-20.79M-9.09%-24.12M-23.67%-97.05M9.89%-19.7M
Net income from continuing operations 9.66%-21.7M332.98%55.41M-8.44%-26.87M11.41%-97.34M5.28%-24.76M-1.18%-24.02M30.19%-23.78M4.43%-24.78M-35.90%-109.87M-11.29%-26.14M
Depreciation and amortization -30.51%369K-33.69%376K-15.37%479K-10.02%2.17M-14.04%508K-13.09%531K-16.12%567K5.60%566K-4.02%2.41M-4.83%591K
Change In working capital 73.92%-410K-112.31%-96K40.93%-1.65M-49.10%-4.61M-132.43%-1.03M80.88%-1.57M-72.74%780K-205.25%-2.79M73.98%-3.09M200.16%3.18M
-Change in receivables -1,840.79%-1.32M-318.85%-2.33M313.08%537K-109.04%-308K-92.51%43K-74.41%76K-86.91%-557K-95.41%130K408.14%3.41M123.25%574K
-Change in prepaid assets -250.29%-2.42M-39.40%463K253.83%803K-530.59%-1.07M-181.20%-622K27.99%-692K1,176.06%764K-643.75%-522K-26.87%-170K75.69%766K
-Change in payables and accrued expense 369.48%1.6M107.17%1.94M-33.63%-2.82M-170.21%-1.68M-96.27%92K91.53%-593K-83.92%934K-11.81%-2.11M-121.25%-621K546.98%2.47M
-Change in other current assets 38,160.00%1.91M-102.78%-1K-68.92%23K106.02%94K-250.00%-21K-28.57%5K102.79%36K127.01%74K-4,438.89%-1.56M73.91%-6K
-Change in other working capital 52.72%-174K59.70%-160K47.37%-190K60.26%-1.65M15.65%-523K34.05%-368K69.18%-397K78.55%-361K69.51%-4.15M58.64%-620K
Cash from discontinued investing activities
Operating cash flow 16.74%-19.07M383.37%58.9M-4.84%-25.28M6.27%-90.97M-17.58%-23.16M17.85%-22.91M24.05%-20.79M-9.09%-24.12M-23.67%-97.05M9.89%-19.7M
Investing cash flow
Cash flow from continuing investing activities -77.13%4.35M-162.93%-12.51M140.59%38.13M-395.59%-36.69M150.48%18.35M934.58%19.02M-36.69%19.88M-577.85%-93.94M109.57%12.41M-299.85%-36.36M
Net PPE purchase and sale 70.77%-19K--083.63%-28K74.12%-508K33.62%-77K77.03%-65K85.20%-195K30.49%-171K-14.59%-1.96M77.65%-116K
Net investment purchase and sale -77.11%4.37M-162.32%-12.51M140.69%38.16M-351.70%-36.18M150.85%18.43M1,056.16%19.09M-38.65%20.07M-571.09%-93.77M111.24%14.38M-322.69%-36.25M
Cash from discontinued investing activities
Investing cash flow -77.13%4.35M-162.93%-12.51M140.59%38.13M-395.59%-36.69M150.48%18.35M934.58%19.02M-36.69%19.88M-577.85%-93.94M109.57%12.41M-299.85%-36.36M
Financing cash flow
Cash flow from continuing financing activities 635K165.49%377K-98.60%1.65M40.08%118.12M31.65%287K0-94.95%142K33,719.83%117.69M-54.79%84.32M-75.53%218K
Net common stock issuance --0--0--045.22%117.35M--0--0--0--117.35M-55.81%80.8M36.36%-49K
Proceeds from stock option exercised by employees --635K165.49%377K374.43%1.65M-77.92%777K7.49%287K--0-94.95%142K0.00%348K-4.06%3.52M-72.45%267K
Cash from discontinued financing activities
Financing cash flow --635K165.49%377K-98.60%1.65M40.08%118.12M31.65%287K--0-94.95%142K33,719.83%117.69M-54.79%84.32M-75.53%218K
Net cash flow
Beginning cash position 150.78%87.92M14.86%41.15M-26.35%26.66M-0.86%36.19M-66.13%31.17M-15.00%35.06M4.13%35.83M-0.86%36.19M-37.22%36.5M38.26%92.03M
Current changes in cash -262.51%-14.09M6,189.58%46.77M4,082.14%14.5M-2,936.62%-9.54M91.91%-4.52M-107.65%-3.89M-111.23%-768K82.66%-364K98.55%-314K-85.76%-55.84M
End cash Position 136.85%73.83M150.78%87.92M14.86%41.15M-26.35%26.66M-26.35%26.66M-66.13%31.17M-15.00%35.06M4.13%35.83M-0.86%36.19M-0.86%36.19M
Free cash flow 16.89%-19.09M380.74%58.9M-4.22%-25.31M7.62%-91.47M-17.28%-23.24M18.44%-22.97M26.86%-20.98M-8.66%-24.29M-23.47%-99.01M11.46%-19.81M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data